DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2293573/is-it-worth-investing-in-cvs-health-cvs-based-on-wall-street-s-bullish-views?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2293573 Jun 26, 2024 - Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://seekingalpha.com/news/4118928-rail-vision-received-follow-on-order-from-us-based-rail-and-leasing-services-company?source=feed_tag_israel Jun 25, 2024 - Rail Vision (RVSN) receives a follow-on order worth $200,000 from a US-based rail and leasing services company, adding to its existing contract. 0

https://www.zacks.com/stock/news/2292820/nextracker-nxt-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2292820 Jun 25, 2024 - Based on the average brokerage recommendation (ABR), Nextracker (NXT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2292134/wall-street-analysts-think-qualcomm-qcom-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2292134 Jun 24, 2024 - Based on the average brokerage recommendation (ABR), Qualcomm (QCOM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2292139/wall-street-analysts-think-abbott-abt-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2292139 Jun 24, 2024 - Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://seekingalpha.com/article/4700614-arkg-a-genomics-play-but-active-isnt-adding-value?source=feed_tag_etf_portfolio_strategy Jun 23, 2024 - Genomics is rapidly advancing, shaping our understanding of health. Read why I’m not sure the ARK Genomic Revolution ETF is the way to play genomics. 0

https://www.fool.com/investing/2024/06/23/is-it-too-late-to-buy-chubb-stock/?source=iedfolrf0000001 Jun 23, 2024 - Berkshire Hathaway recently added 26 million shares of the insurer. 0

https://www.fool.com/investing/2024/06/23/crowdstrike-stock-is-getting-added-to-the-sp-500-b/?source=iedfolrf0000001 Jun 23, 2024 - Although CrowdStrike is a great business, this other company has less valuation risk right now. 0

https://www.fool.com/investing/2024/06/20/fool-foundation-launches-impactfool-fund-opens-cal/?source=iedfolrf0000001 Jun 20, 2024 - The IF Fund will accept nominations from June 20 to July 19 for eligible nonprofits based in the greater Washington, D.C., area. 0

https://seekingalpha.com/article/4700177-rewalk-now-lifeward-medicare-milestone-achieved?source=feed_tag_editors_picks Jun 20, 2024 - ReWalk Robotics achieves Medicare coverage and acquires AlterG, potentially increasing revenue but adding execution risk. Learn more about LFWD stock here. 0